- Systematic review and meta-analysis of five placebo-controlled RCTs (335 participants) testing perioperative pregabalin in adults undergoing elective lumbar spine surgery.
- Pregabalin was compared with placebo, with the primary outcome being pain intensity at 3 months, pooled across four trials (275 participants).
- Pregabalin did not reduce 3-month pain intensity (SMD 0.03, 95% CI -0.41 to 0.47; I² 69%; low certainty).
- Functional disability was lower with pregabalin (SMD -0.51, 95% CI -0.86 to -0.16), but the differences fell below minimal important change thresholds, with very low certainty.
Perioperative medicine
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Systematic review and meta-analysis of seven retrospective cohorts (28,525 patients) comparing lumbar fusion patients with and without preoperative GLP-1RA exposure.
- Six of the seven studies used propensity score matching or another matching strategy to balance the comparison groups.
- No significant association with reoperation or revision (OR 0.74, 95% CI 0.44-1.24; P = 0.25) or postoperative infection (OR 0.83, 95% CI 0.68-1.00; P = 0.05).
- The authors found no signal of increased postoperative risk and called for prospective studies with standardized exposure definitions and perioperative management protocols.
- Systematic review and meta-analysis of 20 studies (n=1979, 11 countries) assessing the furosemide stress test in critically ill adults and children with acute kidney injury.
- For AKI progression, pooled sensitivity was 0.69 and specificity 0.88 (AUC 0.89), with a low-certainty GRADE rating.
- For KRT initiation, sensitivity was 0.81 and specificity 0.75 (AUC 0.79), while mortality prediction was weaker, with sensitivity 0.56 and specificity 0.76.
- FST-guided early KRT initiation had an uncertain effect on short-term mortality (RR 1.00, 95% CI 0.79-1.27; two RCTs, n=212; very low certainty).
- Systematic review and meta-analysis of 58 comparative studies, including 13,530 patients, given fibrinogen concentrate for acquired hypofibrinogenaemia.
- FC was compared with all other treatments, with separate analyses for adult and paediatric patients.
- Adult FC recipients received fewer red cell (IRR 0.72; 95% CI 0.59-0.89; P=0.002), plasma (IRR 0.69; 95% CI 0.54-0.89; P=0.004), and platelet units (IRR 0.56; 95% CI 0.33-0.95; P=0.03).
- No significant difference in mortality or thromboembolic events was found in adults, and the authors concluded FC can reduce adult transfusions without obvious safety concerns.
- Systematic review of three randomized controlled trials including 168 adults with type 2 diabetes undergoing cardiac surgery.
- Compared liraglutide added to insulin with insulin alone or placebo, assessing perioperative glucose, variability, insulin adjustments, and hypoglycemia.
- Liraglutide was associated with lower glucose, reduced glycemic variability, and fewer insulin adjustments, with low hypoglycemia, though the abstract reports no effect sizes or p values.
- Nausea and vomiting were more frequent with liraglutide; the authors call the evidence preliminary and call for larger, standardized trials with long-term outcomes.
- Systematic review and meta-analysis of 19 randomized controlled trials (n = 4,742) comparing neuraxial and general anesthesia in adults undergoing hip fracture surgery.
- Neuraxial anesthesia was compared with general anesthesia across mortality, delirium, cardiac and pulmonary complications, kidney injury, length of stay, and PONV.
- Neuraxial anesthesia was associated with lower intraoperative hypotension (RR 0.55, 95% CI 0.40-0.77), acute kidney injury (RR 0.57, 95% CI 0.38-0.84), and shorter hospital stay (MD -0.58 days, 95% CI -1.08 to -0.07).
- No significant differences were found for mortality at any time point, delirium, ACS, pneumonia, or PONV, and heterogeneity was substantial for some outcomes.
- Bayesian random-effects meta-analysis of 15 randomized trials in major noncardiac surgery, comparing protocolized intraoperative arterial pressure targeting with usual care or lower-pressure approaches.
- Pooled outcomes were all-cause mortality (primary), acute kidney injury, and myocardial injury after noncardiac surgery (MINS).
- Mortality was centered on an OR of 1.00 (95% CI 0.83-1.21), AKI showed OR 0.87 (95% CI 0.73-1.03), and MINS showed OR 1.04 (95% CI 0.93-1.15).
- The authors found no consistent benefit over usual care; AKI estimates were most favorable but uncertain and sensitive to excluding individual trials.
- Systematic review and network meta-analysis of 96 RCTs (N=7396) comparing exercise prehabilitation interventions and their components before surgery.
- Combined aerobic, pulmonary, and functional exercise was most likely to reduce complications (P-score 0.94; OR 0.16, 95% CI 0.05-0.60; very low certainty).
- Combined aerobic, pulmonary, and functional exercise was also most likely to shorten length of stay (P-score 0.97; MD -3.4 days, 95% CI -5.7 to -1.0; moderate certainty).
- Combined aerobic and strength exercise ranked highest for health-related quality of life (SMD 0.67, 95% CI 0.07-1.27; low certainty), while no intervention significantly improved physical recovery.
- Systematic review of 207 randomized controlled trials including 63,785 adults undergoing cardiac surgery, evaluating 55 pharmacological and non-pharmacological interventions to prevent cardiac surgery-associated acute kidney injury.
- Most included trials were small (median sample size 120) and single-center (76.7%), and most reported neutral results (149 of 206).
- Dexmedetomidine (OR 0.48, 95% CI 0.29-0.80), fenoldopam (OR 0.57, 95% CI 0.33-0.98), nitric oxide (OR 0.61, 95% CI 0.43-0.88), and remote ischemic preconditioning (OR 0.78, 95% CI 0.67-0.90) were associated with lower odds of CSA-AKI.
- The authors conclude that only a limited number of interventions were associated with lower odds of CSA-AKI and that these findings need cautious interpretation and confirmation in adequately powered RCTs.
- Systematic review and meta-analysis of 27 randomized controlled trials including 3041 patients undergoing surgery, searched from inception to December 2025.
- Perioperative vitamin C was compared with control; the review pooled effects on pain, opioid use, rescue analgesia, nausea and vomiting, and CRPS-1.
- Vitamin C reduced pain at 24 h (SMD -0.69, 95% CI -0.98 to -0.40) and 24-h morphine use (MD -4.25 mg, 95% CI -6.14 to -2.35), with rescue analgesia also reduced (RR 0.63, 95% CI 0.47 to 0.84).
- Authors say evidence may support reduced acute pain and opioid use with a favorable safety profile, but heterogeneity and publication bias limit it, and routine recommendation is not yet supported; CRPS-1 risk was lower in high-risk orthopedic patients (RR 0.36, 95% CI 0.23 to 0.58).
- Systematic review and meta-analysis of 12 randomised trials (n = 739) comparing remimazolam with sevoflurane for general anaesthesia maintenance or deep sedation.
- Remimazolam was compared with sevoflurane, with outcomes covering intraoperative haemodynamic stability and postoperative nausea and vomiting.
- Remimazolam reduced the risk of intraoperative hypotension versus sevoflurane, RR 0.38 (95% CI 0.25 to 0.57; P < 0.001).
- MAP and heart rate differences appeared only at specific time points, and the PONV reduction came from sensitivity analyses, not the primary analysis.
- Systematic review and meta-analysis of 4 RCTs (7 reports, 446 randomized adults) comparing perioperative subcutaneous liraglutide with placebo or insulin-based usual care in cardiac surgery.
- Liraglutide was compared with placebo or insulin usual care, with glycemic efficacy and hypoglycemia risk as the central questions.
- Liraglutide did not change 30-day mortality (1/161 vs 3/160; RR 0.42, 95% CI 0.06-2.81) or the composite postoperative complication outcome (RR 0.92, 95% CI 0.74-1.14).
- Hypoglycemia was similar (8/165 vs 9/166; RR 0.85, 95% CI 0.34-2.13), and nausea/vomiting estimates were very imprecise (RR 3.01, 95% CI 0.26-35.27).
- Systematic review and meta-analysis of 55 observational studies, with 21 contributing to the meta-analyses, in acutely admitted adult ICU patients.
- Exposure was pre-admission frailty or functional dependency, compared with non-frail or independent status.
- Non-frail versus frail participants had RR 0.62 (95% CI 0.58-0.67, P<0.01) for all-cause mortality; independent versus dependent had RR 0.47 (95% CI 0.40-0.54, P<0.01).
- The authors conclude that frailty and dependency were associated with higher mortality, but certainty of evidence was very low and heterogeneity was substantial.
- Systematic review and meta-analysis of 21 randomized controlled trials including 1271 adults undergoing spinal surgery.
- The exposure was perioperative intravenous magnesium sulfate, with a control group for comparison.
- Magnesium reduced 24-hour pain scores (MD -0.55, 95% CI -1.01 to -0.10, P = 0.02) and opioid consumption (MD -4.95 mg, 95% CI -8.74 to -1.15 mg, P = 0.01).
- Magnesium was associated with less postoperative nausea and vomiting but more hypotension, and with prolonged time to follow commands and recover orientation.
- Systematic review and meta-analysis of 27 studies (n = 21,908) of children under 18 undergoing noncardiac surgery, assessing KDIGO-defined AKI within 7 postoperative days.
- Pooled incidence was reported separately by population because overall pooling was judged uninterpretable given heterogeneity (I² = 98.7%).
- Reported incidence was 22.3% (95% CI 11.2-39.3) after neonatal surgery, 30.1% (95% CI 21.4-40.6) after pediatric liver transplantation, and 9.2% (95% CI 3.3-23.6) in mixed pediatric surgical populations.
- Within mixed surgical populations, AKI rose with higher ASA class (2.4% in ASA 1-2 to 18.9% in ASA 4-5) and fell with age; the authors conclude the true incidence remains uncertain, with certainty rated low to very low.